Funded Tech Companies

Zenas BioPharma

Wondering who invested in Zenas BioPharma? Superstring Capital, Vivo Capital and Enavate Sciences joined the equity holders in this innovative biopharmaceutical company.

Company Overview

Contact Information

Company Background Information

Overview

Zenas BioPharma is a global biopharmaceutical company committed to becoming a leader in the development and commercialization of immunology based therapies for patients in need. Zenas is rapidly advancing a deep pipeline of innovative therapeutics that continues to grow through our successful business development strategy. Our experienced leadership team and network of business partners drive operational excellence to deliver potentially transformative therapies to improve the lives of those facing autoimmune and rare diseases.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

11/8/2022

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Hua Mu

        

Chief Operating Officer

Joe Farmer

        

Founder

Lonnie Moulder

        

Company Investors

• Superstring Capital
• Vivo Capital
• Enavate Sciences
• Pivotal bioVenture Partners
• Wellington Management Company
• Agent Capital
• Longitude Capital Management
• Rock Springs Capital
• Quan Capital
• Xencor
• Tellus BioVentures
• Perceptive Advisors
• Fairmount Funds Management

Browse more funded tech companies:

Zenarate | Zenasis Technologies

Share this article

About Our VC Funding Database

This venture capital transaction data comes via a partnership with VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary